Table 2. Distribution of drug groups dispensed to patients with a new depression diagnosis in 2015 and treated with medication.

Drug group dispensed	n	%
Antidepressant drug only	13 356	85.2
Antipsychotic drug only	745	4.8
Antiepileptic drug only	183	1.2
Antidepressant + antipsychotic	1130	7.2
Antidepressant + antiepileptic	113	0.7
Antipsychotic + antiepileptic	56	0.4
Antidepressant + antipsychotic + antiepileptic	95	0.6
Total	15 678	100

Medications reimbursed for the treatment of depression in Norway (ATC code): antidepressants (N06A).

Non-selective monoamine reuptake inhibitors (N06AA): desipramine, imipramine, imipramine oxide, clomipramine, opipramol, trimipramine, lofepramine, debenzepin, amitriptyline, nortriptyline, doxepin, iprindole, melitracen, butriptyline, dosulepin, amoxapine, dimetacrine, amineptine, maprotiline, quinupramine. Selective serotonin reuptake inhibitors (N06AB): zimeldine, fluoxetine, citalopram, paroxetine, sertraline, alaproclate, fluvoxamine, etoperidone, escitalopram. Monoamine reuptake inhibitors (N06AG): moclobemide, toloxatone. Other antidepressants (N06AX): oxitriptan, tryptophan,mianserin, nomifensine, trazodone, nefazodone, minaprine, bifemelane, viloxazine, oxaflozane, mirtazapine, bupropion, medifoxamine, tianeptine, pivagabine, venlafaxine, milnacipran, reboxetine, gepirone, duloxetine, agomelatine, desvenlafaxine, vilazodone, hyperici herba, vortioxetine.

Antiepileptic drugs (N03A): valproic acid, carbamazepine, lamotrigine.

Antipsychotic drugs (N05A): ziprasidone, loxapine, olanzapine, quetiapine, asenapine, risperidone, aripiprazole, lithium.